Key metrics and charts across all fundamental categories.
Stock price and market valuation
EMR trades at $150.66, a 37.4% increase year-over-year. Market capitalization stands at $84.49B, up 36.9% from the prior year. Track EMR price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$18.32B in TTM revenue grew 4.0% YoY, reaching $4.56B last quarter. TTM EBITDA of $4.47B on operating income of $752.00M shows growth is flowing through. Net income of $2.45B TTM confirms the company is converting revenue into profit. Revenue is growing modestly — monitor for acceleration or deceleration.
Assets, cash, debt, and leverage
With $42.09B in assets and $7.55B in long-term debt, the D/E of 0.4 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
At 34.5x P/E, the stock trades at a premium — the market expects above-average growth. P/S of 4.6x and P/B of 4.2x provide additional context. The premium P/E is not backed by strong revenue growth — the stock may be overvalued.
Operating efficiency and return metrics
Op. margin of 16.5% is up 2.7% YoY — cost efficiency is improving. Net margin at 13.5% and gross margin of 53.1%. ROE of 12.0% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $694.00M on $779.00M in operating cash flow. The FCF / Net Income ratio of 0.3x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $1.79B provide financial flexibility. Share count is stable — no dilution or buyback activity.
